相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New Targets for PET Molecular Imaging of Prostate Cancer
Esther Mena et al.
SEMINARS IN NUCLEAR MEDICINE (2019)
Peptide receptors as cancer drug targets
Terry W. Moody
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2019)
Bombesin conjugated solid lipid nanoparticles for improved delivery of epigallocatechin gallate for breast cancer treatment
Rasika Radhakrishnan et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2019)
Peptide-based targeted polymeric nanoparticles for siRNA delivery
Waleed M. Hussein et al.
NANOTECHNOLOGY (2019)
Bombesin receptors as potential targets for anticancer drug delivery and imaging
Deep Pooja et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2019)
Evaluation of Tumor-Targeting Properties of an Antagonistic Bombesin Analogue RM26 Conjugated with a Non-Residualizing Radioiodine Label Comparison with a Radiometal-Labelled Counterpart
Maryam Oroujeni et al.
PHARMACEUTICS (2019)
Easy formulation of liposomal doxorubicin modified with a bombesin peptide analogue for selective targeting of GRP receptors overexpressed by cancer cells
Antonella Accardo et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2019)
Expression of Gastrin-Releasing Peptide Receptor in Breast Cancer and Its Association with Pathologic, Biologic, and Clinical Parameters: A Study of 1,432 Primary Tumors
Clement Morgat et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Radiolabeled bombesin derivatives for preclinical oncological imaging
Carolina de Aguiar Ferreira et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
High molecular weight PEGylation of human pancreatic polypeptide atposition 22 improves stability and reduces food intake in mice
V. Thieme et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment
Paola Moreno et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Adrenomedullin 2.0: Adjusting Key Levers for Metabolic Stability
Ria Schoenauer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Toward the Optimization of Bombesin-Based Radiotracers for Tumor Targeting
Ibai E. Valverde et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Pre-clinical evaluation of eight DOTA coupled gastrin-releasing peptide receptor (GRP-R) ligands for in vivo targeting of receptor-expressing tumors
Antonella Accardo et al.
EJNMMI RESEARCH (2016)
High metabolic in vivo stability and bioavailability of a palmitoylated ghrelin receptor ligand assessed by mass spectrometry
Katja B. Kostelnik et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
In Vivo Cancer Dual-Targeting and Dual-Modality Imaging with Functionalized Quantum Dots
Kongzhen Hu et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Gastrin-Releasing Peptide Receptor Expression in Lung Cancer
Jane Mattei et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2014)
Phthalocyanine-Peptide Conjugates: Receptor-Targeting Bifunctional Agents for Imaging and Photodynamic Therapy
Elena Ranyuk et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Evolution of Bombesin Conjugates for Targeted PET Imaging of Tumors
Hanwen Zhang et al.
PLOS ONE (2012)
Alpha- versus Beta-Particle Radiopeptide Therapy in a Human Prostate Cancer Model (213Bi-DOTA-PESIN and 213Bi-AMBA versus 177Lu-DOTA-PESIN)
Damian Wild et al.
CANCER RESEARCH (2011)
F-18-Labeled GRPR Agonists and Antagonists: A Comparative Study in Prostate Cancer Imaging
Min Yang et al.
THERANOSTICS (2011)
In Vitro and in Vivo Metabolism of Lu-AMBA, a GRP-Receptor Binding Compound, and the Synthesis and Characterization of Its Metabolites
Karen E. Linder et al.
BIOCONJUGATE CHEMISTRY (2009)
Evaluation of a 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid-Conjugated Bombesin-Based Radioantagonist for the Labeling with Single-Photon Emission Computed Tomography, Positron Emission Tomography, and Therapeutic Radionuclides
Rosalba Mansi et al.
CLINICAL CANCER RESEARCH (2009)
Synthesis, 18F-labeling, and in vitro and in vivo studies of bombesin peptides modified with silicon-based building blocks
Aileen Hoehne et al.
BIOCONJUGATE CHEMISTRY (2008)
Bombesin receptor antagonists may be preferable to agonists for tumor targeting
Renzo Cescato et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours
Hanwen Zhang et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours
M. de Visser et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Chemical and biological characterization of new Re(CO)(3)/[(TC)-T-99m](CO)(3) bombesin analogues
Elisa Garcia Garayoa et al.
NUCLEAR MEDICINE AND BIOLOGY (2007)
In vitro and in vivo antitumor effects of cytotoxic camptothecin-bombesin conjugates are mediated by specific interaction with cellular bombesin receptors
Terry W. Moody et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Potent Bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc:: A preclinical study
BA Nock et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Improving the tumor uptake of 99mTc-labeled neuropeptides using stabilized peptide analogues
P Bläuenstein et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2004)
Targeting gastrin-releasing peptide receptors for cancer treatment
JH Zhou et al.
ANTI-CANCER DRUGS (2004)
Angiotensin-converting enzyme-2 (ACE2): Comparative modeling of the active site, specificity requirements, and chloride dependence
JL Guy et al.
BIOCHEMISTRY (2003)
The angiotensin converting enzyme (ACE)
D Coates
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3
D Weber et al.
JOURNAL OF PEPTIDE SCIENCE (2002)
Discovery of potent and selective peptide agonists at the GRP-preferring bombesin receptor (BB2)
JG Darker et al.
JOURNAL OF PEPTIDE SCIENCE (2001)
分享论文
